Susquehanna International Group’s Sanara MedTech SMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-9,250
Closed -$263K 13769
2025
Q2
$263K Buy
+9,250
New +$277K ﹤0.01% 10638
2023
Q2
Sell
-25,295
Closed -$1.04M 13056
2023
Q1
$1.04M Buy
25,295
+10,068
+66% +$425K ﹤0.01% 6710
2022
Q4
$693K Buy
+15,227
New +$525K ﹤0.01% 7043
2022
Q2
Sell
-15,000
Closed -$416K 13862
2022
Q1
$416K Sell
15,000
-1,800
-11% -$45.7K ﹤0.01% 9446
2021
Q4
$511K Buy
16,800
+3,900
+30% +$123K ﹤0.01% 9147
2021
Q3
$439K Buy
+12,900
New +$463K ﹤0.01% 9719
2021
Q2
Sell
-10,373
Closed -$323K 13211
2021
Q1
$323K Buy
+10,373
New +$359K ﹤0.01% 10449

Other funds holding SMTI

Susquehanna International Group's SMTI Position: Q3 2025 in Review

Susquehanna International Group sold out of Sanara MedTech (SMTI) in Q3 2025, closing a stake of 9,250 shares — an estimated $263K sold.

Susquehanna International Group first reported a position in SMTI in Q1 2021 and held it in 7 quarters. The position peaked at $1.04M in Q1 2023. 58 funds tracked by Wall St. Rank hold SMTI as of Q3 2025.

  • Susquehanna International Group reported no remaining Sanara MedTech position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 9,250 Sanara MedTech shares in Q3 2025, an estimated $263K.
  • Susquehanna International Group first reported a position in Sanara MedTech in Q1 2021 and held it in 7 quarters.
  • Susquehanna International Group's Sanara MedTech position peaked at $1.04M in Q1 2023.
  • 58 funds tracked by Wall St. Rank held Sanara MedTech as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.